Please select a location from the dropdown to view relevant share classes and investments. Your home market is currently
Don't see your home market? Change Edition

The Market Is All In on the Magnificent Seven. Where Should Investors Look Next?

Plus, how to manage the risk of market concentration in your portfolio.

The Market Is All In on the Magnificent Seven. Where Should Investors Look Next?
Watch

Is your portfolio making a big bet on the Magnificent Seven?

Why it matters: Mega-cap names like Nvidia, Alphabet, and Apple belong to the exclusive club that has largely driven US returns higher in recent years. Their success has led to market concentration. Portfolios tracking broad benchmarks have seen their diversification decrease and risk increase. How can you prepare your portfolio to absorb potential shocks? And where are the opportunities beyond the Mag Seven? Morningstar Holland’s Chief European Market Strategist Michael Field is one of the researchers who investigated this.

12 Questions on Opportunities Beyond Magnificent Seven Stocks in 2026

1. The Magnificent Seven’s strong returns have benefited many investors. Why is their dominance a risk?

2. Your team highlighted a noteworthy stat in the report. The top 10 US stocks make up about 35% of the overall market. That’s almost double from a decade ago. What does that signal to you?

3. Can you explain what the hidden cost of market concentration is?

4. If the top stocks hold so much of the gains, where does that leave the rest of the market?

5. Let’s focus on key periods of market concentration. How does the current environment compare to the dot-com bubble?

6. And what about now versus the global financial crisis?

7. What if investors pulled back due to market concentration concerns in the last decade? Why would that have backfired?

8. How can investors manage the risk of market concentration in their portfolios?

9. Morningstar has identified investment opportunities for 2026. Why does the team favor US small caps over US large caps?

10. Another opportunity is the healthcare sector. What companies do Morningstar analysts think could fend off the competition for 10 years or more?

11. Morningstar encourages international diversification. Can you talk about the regions outside the US that look attractive for stock investors?

12. What’s the takeaway for diversifying beyond the Magnificent Seven in 2026?

Key Quote on Opportunities Beyond Magnificent Seven Stocks in 2026

It’s great to have the reward, but what are we risking to get that? And if indeed we’ve got more than a third of our market caps generated all on one sector, then that’s a huge bet, particularly now on AI, as that ramps up. So great, if it works, we’re all going to make a lot of money, but if it doesn’t work, then we’ve got the potential to lose a lot of money.

Michael Field, chief European market strategist, Morningstar Holland

The Takeaway: Be aware of how much exposure you have in your portfolio to Magnificent Seven stocks. Field says it’s fine being exposed to Nvidia and other members of Big Tech. Yet, he cautions against taking on more risk than necessary. Instead, take advantage of opportunities to invest outside the exclusive club in 2026. Attractive valuations exist across the board in areas like the healthcare sector, according to Morningstar researchers. Field reminds investors that diversification would come as an added benefit.

More From Morningstar on Opportunities Beyond Magnificent Seven Stocks in 2026

Some market watchers are comparing the current environment to the dot-com bubble of the late 1990s. During both eras, the 10 largest US stocks held a significant amount of the market capitalization. Field points out that the market is even more concentrated now, and it’s slightly concerning from a risk perspective.

Morningstar’s 2026 global report focuses on preparing investors for what may come next. Doug McGraw, portfolio manager for Morningstar Investment Management, examines how Big Tech’s capital spending will reshape the investment landscape. Read about how market uncertainty will test the discipline of investors and how they can navigate it. And dive deeper into other key challenges investors face this year.

Securities mentioned in this episode:

Nvidia NVDA

Alphabet GOOGL GOOG

Apple APPL

Roche RHHBY

GSK GSK

Novo Nordisk NVO

The author or authors do own shares in any securities mentioned in this article. Find out about Morningstar's editorial policies.